Issue 6/2017
Content (10 Articles)
Open Access
COMMENTARY
Target trial emulation: teaching epidemiology and beyond
Jeremy A. Labrecque, Sonja A. Swanson
COMMENTARY
Prostate cancer incidence as an iceberg
Lorelei A. Mucci, Claire H. Pernar, Sam Peisch, Travis Gerke, Kathryn M. Wilson
META-ANALYSIS
Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling
Tobias Niedermaier, Korbinian Weigl, Michael Hoffmeister, Hermann Brenner
METHODS
The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening
Xabier García-Albéniz, John Hsu, Miguel A. Hernán
SCREENING
Screen-detected gallstone disease and cardiovascular disease
Daniel Mønsted Shabanzadeh, Tea Skaaby, Lars Tue Sørensen, Torben Jørgensen
CANCER
Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?
Morten Valberg, Tom Grotmol, Steinar Tretli, Marit B. Veierød, Tron A. Moger, Susan S. Devesa, Odd O. Aalen
NEW STUDY
A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale
Anssi Auvinen, Antti Rannikko, Kimmo Taari, Paula Kujala, Tuomas Mirtti, Anu Kenttämies, Irina Rinta-Kiikka, Terho Lehtimäki, Niku Oksala, Kim Pettersson, Teuvo L. Tammela
LETTER TO THE EDITOR
Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?
Andrzej Nowakowski, Urszula Wojciechowska, Paulina Wieszczy, Marek Cybulski, Michał F. Kamiński, Joanna Didkowska